Kopran Ltd. (KOPRAN) Share Price Rises 8.29% Today to Rs 237.10
- September 3, 2026
- Posted by: Harsh Piplani
- Category: News
Kopran Ltd. Share Price is trading at Rs 237.10, up 8.29% today, with market capitalisation of Rs 1,051.66 Cr as of 03 September 2026 at 1:49:11 PM IST. The move places Kopran Ltd. Share Price among the notable share price rise names in the healthcare space today. The latest Univest data confirms the gain, but it does not establish a company-specific catalyst. For investors tracking Kopran Ltd. Stock News, the immediate context is the intraday price action, valuation versus peers, and the company’s operating profile in Pharmaceuticals & Drugs. Univest readers looking at Kopran Ltd. Share Price Today can use this event to assess whether the move fits broader stock market today sentiment or remains a stock-specific re-rating within the share market today.
At the time of writing, Kopran Ltd. Share Price was near the day’s high of Rs 238.50 after opening at Rs 214.05 and touching the same level as the day’s low. That shows a firm session so far, with price action moving decisively above the previous close of Rs 218.95. Univest data indicates turnover of Rs 2.69 Cr, which helps frame market interest without changing the central question: what is supporting the share price rise, and what should investors monitor next in Kopran Ltd. Stock Analysis?
Kopran Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 237.1 |
| Previous Close | Rs 218.95 |
| Today's Move | Rs 18.15 (+8.29%) |
| Open | Rs 214.05 |
| High | Rs 238.5 |
| Low | Rs 214.05 |
| Turnover | Rs 2.69 crore |
| Market Capitalisation | Rs 1,051.66 crore |
| Market Cap Category | Small Cap |
Kopran Ltd. (KOPRAN) rose to Rs 237.1 from the previous close of Rs 218.95, a move of Rs 18.15 or 8.29%. The stock opened at Rs 214.05, reached a high of Rs 238.5, recorded a low of Rs 214.05.
Kopran Ltd. Share Price Today reflects a clear intraday recovery from Rs 214.05 to Rs 237.10, a gain of Rs 18.15 or 8.29%. The stock also moved above its previous close of Rs 218.95 and traded close to the day’s high of Rs 238.50. In simple terms, the price rise has been broad enough to stand out in Kopran Ltd. Share Price Live tracking, even though the latest Univest figures do not point to a verified company-specific trigger. For readers following Kopran Ltd. Share Price Update and Kopran Ltd. Share News, the confirmed story is the strength of price action rather than a stated event driver.
That makes Kopran Ltd. Stock Gaining Today a market event first and a news event second. Univest coverage shows the move is relevant for Stocks in News and Top Gainers Today screens because it combines a strong day move with a relatively modest market capitalisation. The stock is trading in the healthcare segment, so the question for Kopran Ltd. Stock Performance is whether today’s interest can be sustained by fundamentals rather than only by sentiment.
Kopran Ltd. (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,051.66 crore |
| P/E Ratio | 42.32x |
| P/B Ratio | 1.97x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.92 |
| Dividend Yield | 1.37% |
Kopran Ltd. (KOPRAN) fundamental metrics show P/E 42.32x, P/B 1.97x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran Ltd. has a market capitalisation of Rs 1051.66 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.32x, P/B at 1.97x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.17, book value per share of Rs 110.92, dividend yield of 1.37%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.97x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.32x |
| Benchmark Median P/E | 31.97x |
| Benchmark Average P/E | 48.6x |
| Benchmark P/E Range | 3.49x to 648.54x |
| Company P/B Ratio | 1.97x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 1,051.66 crore |
| Benchmark Median Market Cap | Rs 727.27 crore |
Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kopran Ltd. (KOPRAN) has a P/E ratio of 42.32x, which is above the benchmark median of 31.97x, a difference of +32.37%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.79%, a difference of -58.27%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.63%, a difference of -51.21%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,179.62 | 38.34 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,301.95 | 83.79 | 13.88 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,622.52 | 87.28 | 21.21 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,114.43 | 25.44 | 4.26 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.87 | 3.25 | 11.83 | 16 |
Kopran Ltd. (KOPRAN) has a P/E ratio of 42.32x compared with the displayed peer median of 38.34x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 1,051.66 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
About Kopran Ltd.
Kopran Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is followed on NSE and BSE as a listed Indian pharma business, and its market capitalisation of Rs 1,051.66 Cr places it among smaller listed healthcare names. For investors researching Kopran Ltd. Share Price, the company overview matters because pharmaceuticals stocks are often assessed through a mix of growth, margins, capital efficiency and industry positioning rather than size alone.
In practical terms, the business belongs to a sector where listed peers include large, diversified pharma companies and more specialised drug makers. That is why Kopran Ltd. Stock Performance is often read through valuation and return metrics alongside company news. Univest readers tracking Kopran Ltd. Latest News and Kopran Ltd. Company News can use this context to understand how the stock fits within the broader Indian stock market healthcare theme.
Frequently Asked Questions
Why is Kopran Ltd. Share Price rising today?
Ans. Kopran Ltd. Share Price is up 8.29% to Rs 237.10, but the latest Univest figures do not establish a company-specific catalyst. The move is confirmed by price action and intraday strength.
What is Kopran Ltd. Share Price Today?
Ans. Kopran Ltd. Share Price Today is Rs 237.10, compared with a previous close of Rs 218.95. The stock is trading higher by Rs 18.15 in the latest session.
How much did Kopran Ltd. stock gain today?
Ans. Kopran Ltd. stock gained 8.29% today. The share price moved from the opening level of Rs 214.05 and stayed near the day’s high of Rs 238.50 during trading.
What is the market capitalisation of Kopran Ltd.?
Ans. Kopran Ltd. has a market capitalisation of Rs 1,051.66 Cr. That places it above the same-industry median but far below the average market cap of larger pharma peers.
What do Kopran Ltd. fundamentals show?
Ans. Kopran Ltd. fundamentals show a P/E of 42.32, P/B of 1.97, ROE of 4.92%, ROCE of 6.65%, EPS of Rs 5.17, book value of Rs 110.92 and dividend yield of 1.37%.
How does Kopran Ltd. compare with pharma peers?
Ans. Compared with peers such as Sun Pharma, Cipla, Zydus and Divi’s, Kopran Ltd. has a smaller market cap, lower ROE and ROCE, and a P/B below most listed comparables in the set.
What sector does Kopran Ltd. belong to?
Ans. Kopran Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That context matters because pharma stocks are often valued on earnings quality, return ratios and peer comparison.
Should investors track Kopran Ltd. Share Price on Univest?
Ans. Yes. Univest lets readers track Kopran Ltd. Share Price, valuation ratios, company context, market cap and sector comparison in one place. That makes it easier to follow Kopran Ltd. Stock News and market updates.
Track Kopran Ltd. Share Price on Univest
Use Kopran Ltd. (KOPRAN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Kopran Ltd. Share Price on Univest for live share price updates, market cap, valuation ratios, fundamentals, sector context and stock updates. Univest also helps users monitor Kopran Ltd. Share Price Today alongside Kopran Ltd. Share News, Kopran Ltd. NSE and Kopran Ltd. BSE references, all in one place.
For a fuller stock analysis experience, Univest brings together Kopran Ltd. Fundamental Analysis, company ratios, market insights and 52-week levels in a format that supports quick research. That makes it easier to follow Kopran Ltd. Share Price Live, compare it with peers and review Kopran Ltd. Stock News without switching between sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
